Two Sigma Investments’s Fennec Pharmaceuticals FENC Stock Holding History

Two Sigma Investments’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,561	Closed	-$120K	–	3030
2023 Q2	$120K	Sell	13,561 -46,809	-78%	-$389K	﹤0.01%	2730
2023 Q1	$502K	Sell	60,370 -27,301	-31%	-$253K	﹤0.01%	2200
2022 Q4	$842K	Buy	+87,671	New	+$776K	﹤0.01%	1783
2020 Q3	–	Sell	-13,828	Closed	-$115K	–	3235
2020 Q2	$115K	Buy	+13,828	New	+$103K	﹤0.01%	2770

Other funds holding FENC

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

SGL

Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Two Sigma Investments's FENC Position: Q3 2023 in Review

Two Sigma Investments sold out of Fennec Pharmaceuticals (FENC) in Q3 2023, closing a stake of 13,561 shares — an estimated $120K sold.

Two Sigma Investments first reported a position in FENC in Q2 2020 and held it in 4 quarters. The position peaked at $842K in Q4 2022. 55 funds tracked by Wall St. Rank hold FENC as of Q3 2023.

Two Sigma Investments reported no remaining Fennec Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Two Sigma Investments sold 13,561 Fennec Pharmaceuticals shares in Q3 2023, an estimated $120K.
Two Sigma Investments first reported a position in Fennec Pharmaceuticals in Q2 2020 and held it in 4 quarters.
Two Sigma Investments's Fennec Pharmaceuticals position peaked at $842K in Q4 2022.
55 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.